Recombinant Human OPA3 Protein，His

The study of OPA3 (Optic Atrophy 3) recombinant protein is pivotal in understanding mitochondrial function and its implications for neurodegenerative diseases. OPA3 is a gene located on chromosome 19, and mutations in this gene are associated with autosomal dominant optic atrophy, a condition characterized by vision loss due to the degeneration of the optic nerve. Research has shown that OPA3 plays a critical role in the maintenance of mitochondrial dynamics and function, including processes such as fusion, fission, and apoptosis. Given its significance in mitochondrial biology, OPA3 has garnered attention as a potential target for therapeutic interventions in diseases linked to mitochondrial dysfunction, such as Leber's hereditary optic neuropathy (LHON) and other hereditary optic neuropathies. The recombinant form of OPA3 allows for detailed studies into its structure-function relationship, biochemical properties, and interaction mechanisms with other mitochondrial proteins. By producing this protein in a controlled laboratory setting, researchers can investigate its role at the molecular level, as well as its impact on cellular health and function. This research not only contributes to the fundamental understanding of mitochondrial-associated diseases but also holds promise for the development of novel therapeutic approaches to mitigate or prevent the effects of OPA3-related conditions. Through the integration of structural biology, genetics, and cellular biology, the study of OPA3 recombinant protein paves the way for new insights into the pathogenesis of optic neuropathies and broader mitochondrial disorders.